1-[[4-[6-Hydroxy-3-[4-(2-piperidin-1-ylethoxy)phenoxy]-1-benzothiophen-2-yl]phenyl]-nitrooxymethyl]cyclopropane-1-carboxylate

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-[[4-[6-Hydroxy-3-[4-(2-piperidin-1-ylethoxy)phenoxy]-1-benzothiophen-2-yl]phenyl]-nitrooxymethyl]cyclopropane-1-carboxylate
• 英文别名: 1-[[4-[6-hydroxy-3-[4-(2-piperidin-1-ylethoxy)phenoxy]-1-benzothiophen-2-yl]phenyl]-nitrooxymethyl]cyclopropane-1-carboxylate
• 化学式: C32H31N2O8S-
• 分子量: 603.7
• InChiKey: HAZYCJCIFSVHIE-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  43
• 可旋转键数：
  10
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.34
• 拓扑面积：
  165
• 氢给体数：
  1
• 氢受体数：
  10

文献信息

• COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS
  申请人：The Board of Trustees of the University of Illinois

  公开号：EP2912033A1

  公开（公告）日：2015-09-02
• [EN] COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS<br/>[FR] COMPOSITIONS ET PROCÉDÉS PERMETTANT DE TRAITER DES AFFECTIONS MÉDICALES ASSOCIÉES AUX ŒSTROGÈNES
  申请人：UNIV ILLINOIS

  公开号：WO2014066695A1

  公开（公告）日：2014-05-01

  Disclosed is a compound of formula (I). or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions including the compound of formula (I) and methods of using the compound of formula (I).